Stock data
Gyre Therapeutics, Inc. (GYRE)
Gyre Therapeutics, Inc. (GYRE) reported revenue of US$116.59M and net income of US$9.88M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$116.59M | — | US$11.49M | US$9.88M | — |
| 2024 | US$105.76M | US$101.87M | US$16.16M | US$17.90M | — |
| 2023 | US$113.45M | US$108.81M | -US$67.23M | -US$85.48M | — |
| 2022 | US$102.29M | US$97.50M | US$9.20M | US$4.31M | — |
| 2021 | US$7.34M | — | -US$87.89M | -US$87.93M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$29.11M | -US$14.27M | — |
| 2026-03-31 | US$22.52M | -US$18.58M | — |
| 2025-12-31 | US$34.23M | US$1.24M | — |
| 2025-09-30 | US$30.56M | US$5.94M | — |
| 2025-06-30 | US$29.73M | -US$2.24M | — |
| 2025-03-31 | US$22.06M | US$4.94M | — |
| 2024-12-31 | US$27.87M | US$0.57M | — |
| 2024-09-30 | US$25.49M | US$2.86M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.